Skip to content
Clinical Trials – home
FranceBack to France

Clinical trials in La Chaussee St Victor

8 clinical trials in La Chaussee St Victor, France. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
La Chaussee St Victor at a glance
8
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

8 trials in La Chaussee St Victor

Open in trial search
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:BioNTech SE
Countries:FranceFrance
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Ivonescimab
  • Sponsor:Groupe Oncologie Radiotherapie Tete Cou
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Unicancer
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Daiichi Sankyo Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Stemline Therapeutics Inc.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Fondation Franc.Cancerologie Digestive
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Abemaciclib
  • Sponsor:Eli Lilly & Co.
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:Astellas Pharma Global Development Inc.

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in La Chaussee St Victor

What the registry says about research in the country

01 Breast Cancer Research

Advanced clinical trials focusing on hormone receptor-positive breast cancer treatments, particularly investigating new therapeutic approaches for patients with high recurrence risk.

  • Endocrine Therapy Comparisons
  • Novel Treatment Combinations
  • ER-Positive HER2-Negative Cancer

These studies aim to improve survival rates and treatment outcomes for breast cancer patients through innovative therapeutic approaches.

02 Pancreatic Cancer Studies

Groundbreaking research exploring targeted therapy approaches for metastatic pancreatic adenocarcinoma, with special focus on CLDN18.2 positive cases.

  • Combination Therapy Assessment
  • Survival Rate Improvement
  • Treatment Tolerability Studies

Researchers are evaluating novel drug combinations to enhance treatment efficacy in advanced pancreatic cancer cases.

03 Advanced Cancer Therapeutics

Comprehensive studies examining targeted endocrine therapies and their combinations for treating advanced stages of hormone-dependent cancers.

  • Progression-Free Survival Analysis
  • Mutation-Specific Treatments
  • Combination Drug Efficacy

These trials are designed to establish more effective treatment protocols for patients with advanced cancer diagnoses.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.